<p><strong>经验丰富的商业和金融领袖带着严谨的增长思维支持 Avid 的下一个扩展阶段和客户执行</strong></p>
<p>, /PRNewswire/ -- Avid Bioservices 是一家领先的合同开发和制造组织（CDMO），为生物制药产品提供工艺开发和 CGMP 制造服务，今天宣布任命 Rich McAvoy 为首席商务官（CBO）。</p>
<p>继续阅读</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Rich McAvoy，首席商务官</p>
<p>McAvoy 是一位受人尊敬的商业导向领导者，拥有丰富的经验，涵盖战略投资管理、运营财务、会计、法律、合规和风险管理。在他的新角色中，他将帮助指导 Avid 的增长战略，重点关注严谨的执行、可扩展的运营和卓越的客户交付。</p>
<p>“随着 Avid 进入下一个增长阶段，我们专注于以增强执行力和提升客户体验的方式扩展组织，” Avid Bioservices 首席执行官 Kenneth Bilenberg 说。“Rich 是一位深思熟虑、能力出众的领导者，以建立支持可靠交付的严谨组织而享有良好声誉。他将战略与执行相结合的能力，同时保持优先级、合规和风险管理的严格性，使他成为 Avid 的绝佳人选。我们很高兴欢迎 Rich 加入团队，随着我们扩展合作伙伴关系，继续提升与我们合作的 CDMO 的标准。”</p>
<p>McAvoy 的任命恰逢生物制药行业的关键时刻，因为许多赞助商正在评估策略，以应对不断变化的地缘政治不确定性、潜在的贸易壁垒以及对美国制造的日益关注，从而增强供应链的韧性。</p>
<p>“Avid 在质量和交付方面建立了良好的声誉，我很高兴在公司有明确增长雄心的时刻加入团队，” Avid Bioservices 的首席商务官 Rich McAvoy 说。“我的重点将是严谨的执行——确保我们继续按时一致交付，同时为客户提供卓越的体验。一致的交付和执行将使我们在竞争对手中脱颖而出，成为首选合作伙伴。”</p>
<p>McAvoy 的任命进一步加强了 Avid 的领导团队，因为公司继续扩展其能力并深化与生物制药创新者的合作关系。Avid 始终致力于帮助客户通过可靠的执行、响应的协作和高质量的 CGMP 制造推进关键项目，覆盖临床和商业供应。</p>
<p><strong>关于 Avid</strong></p>
<p>Avid Bioservices 是一家全球合同开发和制造组织（CDMO），专注于哺乳动物细胞培养制造。总部位于美国，拥有无可挑剔的 FDA 记录，Avid 因其灵活性、质量和应对复杂全球监管环境的能力而受到全球生物制药创新者的信任。Avid 拥有支持新兴生物技术和大型跨国制药公司的经验，提供从开发到商业供应的端到端解决方案。</p>
<p>Avid 的数字：</p>
<ul>
<li>制造超过 600 批次</li>
<li>全球交付超过 275 批商业批次</li>
<li>6 个以上获批的商业产品</li>
<li>在主要监管机构进行 10 次成功的预批准/预许可检查</li>
</ul>
<p>来源 Avid Bioservices</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2NDU4MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUxMzM2UFJfTkVXU19VU1BSX19fX19MQTY0NTgx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2NDU4MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUxMzM2UFJfTkVXU19VU1BSX19fX19MQTY0NTgx"/></p>

CDMO

<p>Avid Bioservices 任命 Rich McAvoy 为首席商务官，以支持其增长战略并提升客户执行力。McAvoy 是一位经验丰富的领导者，在战略投资管理和运营财务方面拥有广泛的经验，他将专注于有序执行和可扩展的运营。他的任命恰逢生物制药行业的关键时刻，强调供应链的韧性和美国本土制造。Avid 旨在增强其在质量和交付方面的声誉，同时扩大与生物制药创新者的合作伙伴关系</p>

<p><strong>Seasoned business and finance leader brings disciplined growth mindset to support Avid's next phase of expansion and client execution</strong></p>
<div class="lb-trans"><p><strong>经验丰富的商业和金融领袖带着严谨的增长思维支持 Avid 的下一个扩展阶段和客户执行</strong></p>
</div><p>, /PRNewswire/ -- Avid Bioservices, a leading contract development and manufacturing organization (CDMO) providing process development and CGMP manufacturing services for biopharmaceutical products, today announced the appointment of Rich McAvoy as Chief Business Officer (CBO).</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Avid Bioservices 是一家领先的合同开发和制造组织（CDMO），为生物制药产品提供工艺开发和 CGMP 制造服务，今天宣布任命 Rich McAvoy 为首席商务官（CBO）。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>继续阅读</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Rich McAvoy, Chief Business Officer</p>
<div class="lb-trans"><p>Rich McAvoy，首席商务官</p>
</div><p>McAvoy is a respected, business-oriented leader with deep experience spanning strategic investment management, operational finance, accounting, legal, compliance, and risk management. In his new role, he will help guide Avid's growth strategy with a focus on disciplined execution, scalable operations, and outstanding customer delivery.</p>
<div class="lb-trans"><p>McAvoy 是一位受人尊敬的商业导向领导者，拥有丰富的经验，涵盖战略投资管理、运营财务、会计、法律、合规和风险管理。在他的新角色中，他将帮助指导 Avid 的增长战略，重点关注严谨的执行、可扩展的运营和卓越的客户交付。</p>
</div><p>&#34;As Avid enters its next chapter of growth, we are focused on scaling the organization in a way that strengthens execution and elevates the client experience,&#34; said Kenneth Bilenberg, Chief Executive Officer of Avid Bioservices. &#34;Rich is a thoughtful, highly capable leader with a strong reputation for building disciplined organizations that support reliable delivery. His ability to connect strategy to execution - while maintaining rigor in prioritization, compliance, and risk management - makes him an exceptional fit for Avid. We are excited to welcome Rich to the team as we expand our partnerships and continue raising the bar on what it means to be the easiest CDMO to work with.&#34;</p>
<div class="lb-trans"><p>“随着 Avid 进入下一个增长阶段，我们专注于以增强执行力和提升客户体验的方式扩展组织，” Avid Bioservices 首席执行官 Kenneth Bilenberg 说。“Rich 是一位深思熟虑、能力出众的领导者，以建立支持可靠交付的严谨组织而享有良好声誉。他将战略与执行相结合的能力，同时保持优先级、合规和风险管理的严格性，使他成为 Avid 的绝佳人选。我们很高兴欢迎 Rich 加入团队，随着我们扩展合作伙伴关系，继续提升与我们合作的 CDMO 的标准。”</p>
</div><p>McAvoy's appointment comes at a pivotal time for the biopharmaceutical industry, as many sponsors evaluate strategies to strengthen supply chain resilience in response to evolving geopolitical uncertainty, potential trade barriers, and increasing focus on U.S.-based manufacturing.</p>
<div class="lb-trans"><p>McAvoy 的任命恰逢生物制药行业的关键时刻，因为许多赞助商正在评估策略，以应对不断变化的地缘政治不确定性、潜在的贸易壁垒以及对美国制造的日益关注，从而增强供应链的韧性。</p>
</div><p>&#34;Avid has built a strong reputation for quality and delivery, and I'm excited to join the team at a time when the company has clear growth ambitions,&#34; said Rich McAvoy, Chief Business Officer of Avid Bioservices. &#34;My focus will be on disciplined execution —ensuring we continue delivering consistently and on time, while supporting an exceptional experience for our customers. Consistent delivery and execution will set us apart from our competitors and make us a preferred partner.&#34;</p>
<div class="lb-trans"><p>“Avid 在质量和交付方面建立了良好的声誉，我很高兴在公司有明确增长雄心的时刻加入团队，” Avid Bioservices 的首席商务官 Rich McAvoy 说。“我的重点将是严谨的执行——确保我们继续按时一致交付，同时为客户提供卓越的体验。一致的交付和执行将使我们在竞争对手中脱颖而出，成为首选合作伙伴。”</p>
</div><p>McAvoy's appointment further strengthens Avid's leadership team as the company continues expanding its capabilities and deepening partnerships with biopharmaceutical innovators. Avid remains committed to helping customers advance critical programs with reliable execution, responsive collaboration, and high-quality CGMP manufacturing across clinical and commercial supply.</p>
<div class="lb-trans"><p>McAvoy 的任命进一步加强了 Avid 的领导团队，因为公司继续扩展其能力并深化与生物制药创新者的合作关系。Avid 始终致力于帮助客户通过可靠的执行、响应的协作和高质量的 CGMP 制造推进关键项目，覆盖临床和商业供应。</p>
</div><p><strong>About Avid</strong></p>
<div class="lb-trans"><p><strong>关于 Avid</strong></p>
</div><p>Avid Bioservices is a global contract development and manufacturing organization (CDMO) specializing in mammalian cell-culture manufacturing. Headquartered in the U.S. with a flawless FDA record, Avid is trusted by biopharmaceutical innovators worldwide for its agility, quality, and ability to navigate complex global regulatory landscapes. With experience supporting both emerging biotech and large multinational pharma companies, Avid provides end-to-end solutions from development through commercial supply.</p>
<div class="lb-trans"><p>Avid Bioservices 是一家全球合同开发和制造组织（CDMO），专注于哺乳动物细胞培养制造。总部位于美国，拥有无可挑剔的 FDA 记录，Avid 因其灵活性、质量和应对复杂全球监管环境的能力而受到全球生物制药创新者的信任。Avid 拥有支持新兴生物技术和大型跨国制药公司的经验，提供从开发到商业供应的端到端解决方案。</p>
</div><p>Avid By the Numbers:</p>
<div class="lb-trans"><p>Avid 的数字：</p>
</div><ul>
<li>More than 600 batches manufactured</li>
<li>Over 275 commercial batches delivered globally</li>
<li>6+ approved commercial products</li>
<li>10 successful pre-approval/pre-license inspections across major regulatory agencies</li>
</ul>
<div class="lb-trans"><ul>
<li>制造超过 600 批次</li>
<li>全球交付超过 275 批商业批次</li>
<li>6 个以上获批的商业产品</li>
<li>在主要监管机构进行 10 次成功的预批准/预许可检查</li>
</ul>
</div><p>SOURCE Avid Bioservices</p>
<div class="lb-trans"><p>来源 Avid Bioservices</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTE1Jk5ld3NJdGVtSWQ9TEE2NDU4MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMTUxMzM2UFJfTkVXU19VU1BSX19fX19MQTY0NTgx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA64581&amp;Transmission_Id=202601151336PR_NEWS_USPR_____LA64581&amp;DateId=20260115"/></p>